[NEFA behavior and its correlations with IRI during IVGTT in normal, obese and diabetic subjects]. 1979

R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and R Prando, and L Adezati

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and R Prando, and L Adezati
May 1979, Minerva medica,
R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and R Prando, and L Adezati
May 1979, Minerva medica,
R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and R Prando, and L Adezati
January 1984, Acta diabetologica latina,
R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and R Prando, and L Adezati
January 1977, Archivio per le scienze mediche,
R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and R Prando, and L Adezati
September 1979, Minerva medica,
R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and R Prando, and L Adezati
September 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and R Prando, and L Adezati
June 1975, Israel journal of medical sciences,
R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and R Prando, and L Adezati
June 1995, Nihon rinsho. Japanese journal of clinical medicine,
R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and R Prando, and L Adezati
December 1979, Bollettino della Societa italiana di biologia sperimentale,
R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and R Prando, and L Adezati
February 1976, The New England journal of medicine,
Copied contents to your clipboard!